US 12188005
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12188005 (NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K2039/57, A61K2039/572